[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2508-2509]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01327]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-19-0571]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Minimum Data Elements (MDEs) for the National
Breast and Cervical Cancer Early Detection Program (NBCCEDP) to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on March 5, 2018 to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Minimum Data Elements (MDEs) for the National Breast and Cervical
Cancer Early Detection Program (NBCCEDP)--(OMB No. 0920-0571, exp. 12/
31/2018)--Reinstatement with Change--National Center for Chronic
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease
Control and Prevention (CDC)
Background and Brief Description
CDC is requesting a Reinstatement with Change to OMB No. 0920-0571.
Based on feedback from grantees and internal subject matter experts,
CDC proposes use of revised minimum data elements (MDEs).
Both breast and cervical cancers are prevalent among U.S. women--in
2014, more than 236,000 women were diagnosed with breast cancer, and
more than 12,000 women were diagnosed with cervical cancer. Evidence
shows that deaths from both breast and cervical cancers can be avoided
by increasing screening services--mammography and Pap tests--among
women. However, screening is typically underutilized among women who
are under- or uninsured, have no regular source of healthcare, or who
recently immigrated to the U.S.
Congress passed the Breast and Cervical Cancer Mortality Prevention
Act of 1990, which directed CDC to establish the National Breast and
Cervical Cancer Early Detection Program (NBCCEDP). The purpose of the
NBCCEDP is to increase breast and cervical cancer screening rates among
priority populations by funding grantees to provide breast and cervical
cancer screening services to eligible women. CDC issued a new funding
opportunity announcement to support a five-year cooperative agreement
under CDC-RFA-DP17-1701. The number of grantees will increase from 67
grantees to 70 grantees.
CDC proposes a Reinstatement with Change to the MDEs to include
removal of several data variables that are no longer relevant for CDC
analyses, as well as collapsing/revising several data variables to
reduce burden and increase clarity for respondents. The MDEs focus on:
(1) Patient demographics, (2) breast cancer screening, (3) cervical
cancer screening, (4) breast and cervical cancer diagnoses, (5) breast
and cervical cancer treatment, (6) timeliness of services, and (7)
patient navigation.
Redesigned data elements will enable CDC to better gauge progress
in meeting clinical service delivery processes and patient-level
outcomes. Findings will allow CDC to assess program progress in meeting
goals and monitor implementation activities, evaluate outcomes, and
identify grantee technical assistance needs. In addition, data
collected will inform program improvement and help identify successful
activities that need to be maintained, replicated, or expanded.
OMB approval is requested for three years. The total estimated
annualized burden hours will decrease from 536 to 350 hours. There are
no costs to respondents other than their time.
[[Page 2509]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Grantees.................... MDES...................... 70 2 150/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2019-01327 Filed 2-6-19; 8:45 am]
BILLING CODE 4163-18-P